Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The new campus has been designed as an employee-centred experience and ecosystem zone
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Subscribe To Our Newsletter & Stay Updated
